Company profile: Financière de Tubize
1.1 - Company Overview
Company description
- Provider of investment holding focused on the biopharmaceutical industry, operating worldwide through its interest in UCB.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Financière de Tubize
Oruka Therapeutics
HQ: United States
Website
- Description: Provider of biologic therapies for chronic skin diseases, including monoclonal antibodies: ORKA-001 targeting IL-23p19 for psoriasis and other inflammatory diseases; ORKA-002 targeting IL-17A/F for psoriasis and other inflammatory diseases; and ORKA-003, a discovery-stage program for psoriasis, psoriatic arthritis, and related conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oruka Therapeutics company profile →
Javara
HQ: United States
Website
- Description: Provider of integrated clinical research services to healthcare organizations, delivering turnkey, practice-based clinical trial infrastructure to expand access to clinical trials and change the clinical research experience for providers and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Javara company profile →
AGC Biologics
HQ: Denmark
Website
- Description: Provider of biopharmaceutical contract development and manufacturing services, including microbial fermentation and mammalian cell culture cGMP manufacturing, process development and scale-up, and production of biopharmaceuticals for pre-clinical, clinical, and market supply. Offers CDMO services for biologics and ATMPs, AGCellerate (DNA-to-IND), lentiviral and AAV vector production, and ADC development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AGC Biologics company profile →
Evergreen Theragnostics
HQ: United States
Website
- Description: Provider of radiopharmaceutical contract development and manufacturing services, covering early-stage development through commercial production. The company develops and commercializes radiopharmaceuticals (e.g., Ga-68 DOTATOC), discovers novel radiopharmaceuticals for unmet clinical needs in cancer treatment, and operates an Alpha Therapy Line for GMP Ac-225 products and a Springfield facility compliant with US FDA 21 CFR 211 and EMA cGMP.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evergreen Theragnostics company profile →
Optivia
HQ: United States
Website
- Description: Provider of contract research services for the pharmaceutical industry, advancing the utility of transporter research across pharmacokinetics, toxicology, therapeutic target discovery, and basic biology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Optivia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Financière de Tubize
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Financière de Tubize
2.2 - Growth funds investing in similar companies to Financière de Tubize
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Financière de Tubize
4.2 - Public trading comparable groups for Financière de Tubize
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →